Furthermore, expression of cortactin, cyclin D1 and more recently FADD (Gibcus et al, 2007b), have been described separately as potential predictors for increased disease-related mortality, for lymph node metastasis and poor prognosis. The gene discussed is CTTN; the disease is metastatic malignant neoplasm in the lymph nodes.